Related Experiment Video
Updated: Mar 11, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
The Kidney in Hypertension
Hillel Sternlicht1, George L Bakris1
1Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, ASH Comprehensive Hypertension Center, The University of Chicago Medicine, 5841 South Maryland Avenue, MC 1027, Chicago, IL 60637, USA.
Insights
Hypertension and chronic kidney disease (CKD) are closely linked. Recent advances in blood pressure, glycemic, and cholesterol control have significantly slowed CKD progression and reduced albuminuria over 3 decades.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Hypertension is a leading cause of chronic kidney disease (CKD) and accelerates kidney failure.
- CKD can also lead to resistant hypertension, creating a complex clinical challenge.
- Nephropathy progression has historically been rapid, contributing to significant morbidity.
Purpose of the Study:
- To analyze trends in nephropathy progression over the past three decades.
- To evaluate the impact of improved management strategies on CKD and related complications.
- To understand the relationship between hypertension, CKD, and albuminuria levels.
Main Methods:
- Retrospective analysis of patient data over a 30-year period.
- Examination of trends in kidney function decline (mL/min per year).
- Assessment of changes in albuminuria incidence and progression rates.
Main Results:
- Nephropathy progression has slowed significantly, from 8 mL/min/year to 2-3 mL/min/year.
- The incidence of very high albuminuria and progression from high to very high levels has decreased.
- Improvements correlate with better blood pressure, glycemic, and cholesterol management.
Conclusions:
- Enhanced control of hypertension, diabetes, and hyperlipidemia has markedly improved CKD outcomes.
- These advancements have substantially reduced the rate of kidney function decline and albuminuria.
- Current therapeutic strategies are effective in slowing the progression of hypertensive nephropathy.
Abstract:
Hypertension is the second most common cause of chronic kidney disease (CKD) and is a potentiator of kidney failure when accompanying disease. CKD is a common cause of resistant hypertension. Nephropathy progression has dramatically slowed over the past 3 decades from an average of 8 to between 2-3 mL/min per year regardless of diabetes status. The incidence of very high albuminuria as well as progression from high albuminuria very high albuminuria has substantially decreased over the past 3 decades. This improvement relates to better blood pressure control using agents that slow nephropathy as well as better glycemic and cholesterol control.
More Related Videos
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Potassium-Sparing Diuretics
Chronic Kidney Disease I: Introduction
Hypertension II: Pathophysiology
Antihypertensive Drugs: Action of Diuretics
Chronic Kidney Disease III: Interprofessional Care

